Cargando…
Sequential Combination Chemotherapy of Dacarbazine (DTIC) with Carboplatin and Paclitaxel for Patients with Metastatic Mucosal Melanoma of Nasal Cavity and Paranasal Sinuses
By the recent introduction of molecular targeting drugs against BRAF mutation and immune checkpoint inhibitors, the prognosis of patients with melanoma in advanced stage is now improving, but still in the minority. Mucosal melanoma lacks the BRAF mutations, and hence conventional chemotherapeutic re...
Autores principales: | Omata, W., Tsutsumida, A., Namikawa, K., Takahashi, A., Oashi, K., Yamazaki, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224238/ https://www.ncbi.nlm.nih.gov/pubmed/28096700 http://dx.doi.org/10.4137/CCRep.S39851 |
Ejemplares similares
-
Nasal Cavity and Paranasal Sinuses
por: Cardesa, A., et al.
Publicado: (2006) -
Nasal Cavity and Paranasal Sinuses
por: Cardesa, Antonio, et al.
Publicado: (2017) -
Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.
por: Mulder, N. H., et al.
Publicado: (1994) -
Inflammatory diseases of the nasal cavities and paranasal sinuses
por: Helliwell, Tim
Publicado: (2010) -
Primary Burkitt's Lymphoma in the Nasal Cavity and Paranasal Sinuses
por: Lee, Dong Hwan, et al.
Publicado: (2013)